Clinical Implications of Malnutrition in the Management of Patients with Pancreatic Cancer: Introducing the Concept of the Nutritional Oncology Board

• Published in: Nutrients 2021-10, Vol.13 (10), p.3522
• Main Authors: Rovesti, Giulia, Valoriani, Filippo, Rimini, Margherita, Bardasi, Camilla, Ballarin, Roberto, Di Benedetto, Fabrizio, Menozzi, Renata, Dominici, Massimo, Spallanzani, Andrea
• Format: Article
• Language: English
• Subjects: Anorexia; Body fat; Body mass index; Cachexia; Cachexia - etiology; Cachexia - therapy; Cancer therapies; Chemotherapy; Clinical nutrition; Cocaine; Cytokines; Dietetics - methods; Exocrine Pancreatic Insufficiency - etiology; Exocrine Pancreatic Insufficiency - therapy; Humans; Inflammation; Insulin; Kinases; Malignancy; Malnutrition; Malnutrition - etiology; Malnutrition - therapy; Medical Oncology - methods; Metabolism; Metastases; Mortality; Musculoskeletal system; Nutrition; Nutrition therapy; Nutritional Support; Obesity; Oncology; Pancreatic cancer; Pancreatic Neoplasms - complications; Patients; Proteins; Quality of life; Review; Sarcopenia; Sarcopenia - etiology; Sarcopenia - therapy; Specialty Boards; Tumor necrosis factor-TNF; Tumors; Weight control
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu13103522

Pancreatic cancer represents a very challenging disease, with an increasing incidence and an extremely poor prognosis. Peculiar features of this tumor entity are represented by pancreatic exocrine insufficiency and an early and intense nutritional imbalance, leading to the highly prevalent and multifactorial syndrome known as cancer cachexia. Recently, also the concept of sarcopenic obesity has emerged, making the concept of pancreatic cancer malnutrition even more multifaceted and complex. Overall, these nutritional derangements play a pivotal role in contributing to the dismal course of this malignancy. However, their relevance is often underrated and their assessment is rarely applied in clinical daily practice with relevant negative impact for patients' outcome in neoadjuvant, surgical, and metastatic settings. The proper detection and management of pancreatic cancer-related malnutrition syndromes are of primary importance and deserve a specific and multidisciplinary (clinical nutrition, oncology, etc.) approach to improve survival, but also the quality of life. In this context, the introduction of a "Nutritional Oncology Board" in routine daily practice, aimed at assessing an early systematic screening of patients and at implementing nutritional support from the time of disease diagnosis onward seems to be the right path to take.